Publication date: Aug 12, 2026
Health care worker (HCW) infections during outbreaks of high-consequence pathogens, from SARS-CoV-2 to Ethiopia’s 2025-2026 Marburg outbreak, highlight persistent Infection Prevention and Control (IPC) gaps. We evaluated IPC adherence and its determinants among infected HCWs in Addis Ababa, Ethiopia, to inform future outbreak preparedness. This census-based cross-sectional study (March 2020-March 2021) evaluated 1152 SARS-CoV-2-infected HCWs with clinical exposures 14 days pre-diagnosis. Environments were classified via an adapted OSHA pyramid into: High-Pathogen Designated Areas isolation and treatment units, General High-Risk Areas [intensive care units, emergency departments, and operating theaters], Medium-Risk Clinical Areas [inpatient and outpatient departments], and Low-Risk Support Areas [administrative and non-clinical zones]. Adherence was defined as correct practice in > 50% of interactions. Bivariate chi-square tests and multivariable logistic regression identified independent determinants for donning/doffing (n = 742) and N95 seal-checks (n = 350), reporting adjusted odds ratios (aOR) with 95% confidence intervals at P 30 [aOR = 0. 57 (0. 34-0. 98)] and stress [aOR = 0. 46 (0. 28-0. 77)] were negative determinants. This study underscores IPC gaps among HCWs especially in non-designated areas, where most infections occurred, highlighting the need for standardized IPC across all healthcare environments.
Open Access PDF
| Concepts | Keywords |
|---|---|
| COVID-19 | |
| Cross-sectional studies | |
| Ethiopia | |
| Guideline adherence | |
| Health Personnel | |
| Infection control | |
| Occupational exposure | |
| Personal protective equipment |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Infection |
| disease | MESH | persistent Infection |
| disease | MESH | emergency |
| pathway | REACTOME | Reproduction |
| disease | MESH | included |
| disease | MESH | COVID 19 |
| disease | MESH | critical illness |
| disease | MESH | face |
| disease | MESH | Marburg Virus Disease |
| disease | MESH | infectious diseases |
| disease | MESH | LRS |
| disease | MESH | dis |
| drug | DRUGBANK | Etoperidone |
| disease | MESH | ers |
| drug | DRUGBANK | Hyaluronic acid |
| disease | MESH | fever |
| drug | DRUGBANK | Coenzyme M |
| disease | MESH | mend |
| drug | DRUGBANK | Sodium lauryl sulfate |
| disease | MESH | SDs |